INDIAGLYCO NSE filing

India Glycols Approves Audited FY26 Results; Declares Interim Dividend

The RealCase readHigh impact Positive

India Glycols Limited reported audited standalone results for the quarter and year ended March 31, 2026. Profit After Tax for the quarter was ₹110.28 crore, up from ₹50.35 crore last year. Full-year Profit After Tax was ₹282.33 crore, up from ₹180.38 crore. The company declared an interim dividend of ₹7.50 per share.

Why it matters

The approval of audited financial results and declaration of interim dividend are material events for shareholders and investors, impacting the company's valuation and investment decisions.

The market read

The company reported a significant increase in profit after tax for both the quarter and the full financial year compared to the previous year, and declared an interim dividend, indicating positive financial performance and shareholder returns.

India Glycols Limited announced the outcome of its Board Meeting held on 14th May 2026. The Board approved the audited financial results (standalone and consolidated) for the quarter and financial year ended 31st March 2026.

The company reported a Profit After Tax of ₹110.28 crore for the quarter ended March 31, 2026, compared to ₹50.35 crore in the same quarter last year. For the full financial year ended March 31, 2026, the Profit After Tax stood at ₹282.33 crore, a significant increase from ₹180.38 crore in the previous year.

Revenue from operations for the quarter was ₹2,361.40 crore, and for the full year, it was ₹9,826.20 crore.

The Board also approved an interim dividend of ₹7.50 per equity share (face value of ₹5) for the financial year 2025-26, declared on March 17, 2026.

The financial results have been audited by K.N. Gutgutia & Co. and have received an unmodified opinion. The Board Meeting commenced at 16:15 Hrs. and concluded at 17:25 Hrs.

Filing to action

What to do with a filing like this

India Glycols Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by India Glycols Limited. Read the original for the full detail.

View original filing